Innovative Chemical Approach Revitalizes Malaria Drug Effectiveness

Researchers have pioneered a chemical modification that enhances the solubility and efficacy of a malaria drug, offering new hope against resistant strains. Learn how this breakthrough could revolutionize malaria treatment.
Researchers at the University of California, San Francisco, have discovered a novel chemical modification that transforms a once-failing malaria medication into a potent, easy-to-administer drug. Malaria remains a global health challenge, claiming approximately 600,000 lives annually, predominantly children in Sub-Saharan Africa. The increasing resistance of the malaria parasite to existing treatments has necessitated the development of new therapies.
The team focused on artefenomel, an artemisinin-inspired compound originally designed to replace combination therapies due to its potential to cure malaria with a single dose. However, clinical trials revealed significant challenges: artefenomel's high symmetry caused it to form crystals, hindering its dissolution and making it difficult to develop as a practical oral pill. It also proved problematic in pediatric treatments, where the suspension form was hard for children to swallow and ensure accurate dosing.
To address these issues, scientists manipulated the molecular structure, reducing its symmetry to prevent crystallization and enhance solubility. The modified molecules dissolved instantaneously in water, facilitating easier formulation into pills. Subsequent testing confirmed that these new compounds remained highly effective against malaria parasites, including strains resistant to artemisinin, and could be produced inexpensively.
This breakthrough offers hope for more effective, accessible malaria treatments, especially critical as resistance spreads into Africa, where most cases and fatalities occur. The findings suggest that simple chemical tweaks can revitalize existing drugs, providing a new path forward in the fight against resistant malaria strains.
The research has been published in Science Advances and signifies a promising step towards developing more reliable and straightforward antimalarial medications.
Source: https://medicalxpress.com/news/2025-08-chemical-malaria-drug-winner.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Challenges Faced by Nurses in Providing End-of-Life Care in Aged Care Homes
Recent research highlights the barriers nurses face in delivering quality end-of-life care in Australian aged care homes, emphasizing the need for systemic reform and targeted support to improve resident outcomes.
Innovative Research Identifies Brain Protein That Could Lead to New Parkinson's Disease Treatments
University of Sydney researchers discover a brain protein involved in Parkinson's disease, opening new avenues for treatment strategies that could slow disease progression.
NICE's cautious stance on new Alzheimer's treatments: A reasoned approach
NICE has declined to recommend two new Alzheimer's drugs for NHS use, citing modest benefits, risks, and high costs. This decision emphasizes careful evaluation to ensure responsible treatment choices for dementia care.